Fulgent Genetics (FLGT) Operating Leases (2019 - 2025)
Historic Operating Leases for Fulgent Genetics (FLGT) over the last 6 years, with Q3 2025 value amounting to $3.6 million.
- Fulgent Genetics' Operating Leases fell 2230.8% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 2230.8%. This contributed to the annual value of $4.1 million for FY2024, which is 4235.34% down from last year.
- Latest data reveals that Fulgent Genetics reported Operating Leases of $3.6 million as of Q3 2025, which was down 2230.8% from $3.8 million recorded in Q2 2025.
- Fulgent Genetics' 5-year Operating Leases high stood at $8.8 million for Q4 2022, and its period low was $3.6 million during Q3 2025.
- In the last 4 years, Fulgent Genetics' Operating Leases had a median value of $4.7 million in 2024 and averaged $5.5 million.
- Its Operating Leases has fluctuated over the past 5 years, first plummeted by 1873.79% in 2023, then plummeted by 4737.95% in 2025.
- Over the past 4 years, Fulgent Genetics' Operating Leases (Quarter) stood at $8.8 million in 2022, then decreased by 18.74% to $7.1 million in 2023, then crashed by 42.35% to $4.1 million in 2024, then dropped by 12.09% to $3.6 million in 2025.
- Its Operating Leases was $3.6 million in Q3 2025, compared to $3.8 million in Q2 2025 and $3.9 million in Q1 2025.